AI Startups - Latest Funding Deal: Clearly raised $4.3M Seed round

AI Startups - Latest Funding Deal: ELISE raised $75M Series D round

Artificial Intelligence | Machine Learning | Natural Language Processing Emedgene | Automatically Interpret Genetic Tests

Healthcare, Technology, Genomics, Human Genetics, Big Data, NLP Palo Alto, CA, United States

Artificial Intelligence | Machine Learning | Natural Language Processing

Emedgene | Automatically Interpret Genetic Tests

Healthcare, Technology, Genomics, Human Genetics, Big Data, NLP

Palo Alto, CA, United States

Emedgene - AI Startup | AI Startup Profile Powered by Appengine AI | Appengine AI - World's Most Promising AI Startups & AI Ecosystem of 10,000+ AI Startups Get Started

Emedgene is the world’s first completely automated genetic interpretation platform. We’re applying the most advanced AI technologies in order to dramatically scale genetic interpretation and discovery. Clinical labs using Emedgene improve dry lab efficiency, reducing time spent on interpretation and reporting, increasing yield, and scaling their genomic interpretation operation. Research organizations using Emedgene accelerate genomic-driven discovery through the application of end-to-end AI, from NLP of publications, through custom machine learning algorithms.

While sequencing is becoming easier, interpreting results is a manual and lengthy research process that forms a bottleneck to the adoption of genetic-based care. Emedgene uses NLP to ‘read’ new genetic publications, and incorporate them into an always up-to-date knowledge base. We then run machine learning discovery algorithms that pinpoint pathogenic variants, for a clear path to clinical decisions. Clinical labs using Emedgene improve dry lab efficiency, reduce time spent on interpretation and reporting, and increase yield without increasing headcount.